Top Markets
Coin of the day
Neuropathix, Inc. Neuropathix, Inc.

Neuropathix, Inc.

NPTX
Clasificación en acciones #41304
Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying,... Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying, advancing, and bringing to market innovative treatments derived from its exclusive platform of synthetic cannabinoid derivatives. The company's efforts are concentrated on the research and preclinical development of chemical compounds like KLS-13019, KLS-13023, and KLS-13022, alongside associated molecules and synthetic cannabidiol-based therapies. These investigational drugs are being explored for their potential application in treating various conditions, including chemotherapy-induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. Previously operating as Kannalife, Inc., the organization rebranded as Neuropathix, Inc. in November 2020. Established in 2010, Neuropathix, Inc. maintains its headquarters in Doylestown, Pennsylvania.
Precio por acción
$0.0003
Última sincronización: 2023-06-13
Capitalización bursátil
$28.14K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Neuropathix, Inc. (NPTX)

Categoría

Historial del precio de la acción de Neuropathix, Inc. (NPTX)
Precio más alto de cierre: $0.00 el 2023-06-01

Precio más bajo de cierre: $3.83 el 2019-12-01
Historial del precio de la acción de Neuropathix, Inc. desde 2019 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2023 -94.99%
2022 -87.62%
2021 -79.16%
2020 -93.93%
2019 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$527.87 33.33%
US
$873.57 35.10%
NL
$745.48 9.02%
CH
$1.08K -6.68%
KR
$260.24 16.81%
BE